{"news_desk": "Business", "print_page": null, "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By NEIL UNMACK", "person": [{"rank": 1, "role": "reported", "firstname": "Neil", "organization": "", "lastname": "UNMACK"}]}, "abstract": null, "type_of_material": "News", "word_count": "364", "lead_paragraph": "A friendly takeover deal for Allergan\u2019s generic drugs unit is far easier than the hostile bid that Teva was pursuing for Mylan.", "pub_date": "2015-07-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Teva\u2019s Deal for Allergan Unit Allows Graceful Exit From Mylan Fray", "content_kicker": "Breakingviews", "kicker": "Breakingviews"}, "snippet": "A friendly takeover deal for Allergan\u2019s generic drugs unit is far easier than the hostile bid that Teva was pursuing for Mylan.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/07/28/business/dealbook/tevas-deal-for-allergan-units-allows-graceful-exit-from-mylan-fray.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Allergan Inc", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Mylan Inc", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "6", "is_major": "N", "value": "Actavis PLC", "name": "organizations"}], "blog": [], "_id": "55b65ce138f0d860ec81da6d", "source": "The New York Times"}